ROCKVILLE, Md. (AP) — ROCKVILLE, Md. (AP) — MacroGenics Inc. (MGNX) on Tuesday reported a loss of $55.7 million in its second quarter.

On a per-share basis, the Rockville, Maryland-based company said it had a loss of 89 cents.

The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 47 cents per share.

The biopharmaceutical company posted revenue of $10.8 million in the period, which also did not meet Street forecasts. Four analysts surveyed by Zacks expected $24.1 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MGNX at https://www.zacks.com/ap/MGNX